Wu Yue, Wood James, Khandaker Gulam, Waddington Claire, Snelling Thomas
Wesfarmers Centre of Vaccines & Infectious Diseases, Telethon Kids Institute, University of Western Australia, Australia.
School of Public Health and Community Medicine, University of New South Wales, Australia.
Vaccine. 2016 Nov 4;34(46):5636-5642. doi: 10.1016/j.vaccine.2016.09.010. Epub 2016 Sep 23.
An estimated 110,000 babies are born with congenital rubella syndrome (CRS) worldwide annually; a significant proportion of cases occur in Southeast Asia. Rubella vaccine programs have led to successful control of rubella and CRS, and even the elimination of disease in many countries. However, if vaccination is poorly implemented it might increase the number of women reaching childbearing age who remain susceptible to rubella and thereby paradoxically increase CRS. We used an age-structured transmission model to compare seven alternative vaccine strategies for their impact on reducing CRS disease burden in East Java, a setting which is yet to implement a rubella vaccine program. We also investigated the robustness of model predictions to variation in vaccine coverage and other key epidemiological factors. Without rubella vaccination, approximately 700 babies are estimated to be born with CRS in East Java every year at an incidence of 0.77 per 1000live births. This incidence could be reduced to 0.0045 per 1000 live births associated with 99.9% annual reduction in rubella infections after 20 years if the existing two doses of measles vaccine are substituted with two doses of measles plus rubella combination vaccine with the same coverage (87.8% of 9-month-old infants and 80% of 6-year-old children). By comparison a single dose of rubella vaccine will take longer to reduce the burden of rubella and CRS and will be less robust to lower vaccine coverage. While the findings of this study should be informative for settings similar to East Java, the conclusions are dependent on vaccine coverage which would need consideration before applying to all of Indonesia and elsewhere in Asia.
据估计,全球每年有110000名婴儿出生时患有先天性风疹综合征(CRS);其中很大一部分病例发生在东南亚。风疹疫苗计划已成功控制了风疹和CRS,甚至在许多国家消除了该疾病。然而,如果疫苗接种实施不当,可能会增加达到育龄但仍易感染风疹的女性数量,从而反常地增加CRS病例。我们使用了一个年龄结构传播模型,比较了七种替代疫苗策略对东爪哇省降低CRS疾病负担的影响,该地区尚未实施风疹疫苗计划。我们还研究了模型预测对疫苗覆盖率变化和其他关键流行病学因素的稳健性。如果不接种风疹疫苗,估计东爪哇省每年约有700名婴儿出生时患有CRS,发病率为每1000例活产0.77例。如果用两剂相同覆盖率(9个月大婴儿的87.8%和6岁儿童的80%)的麻疹加风疹联合疫苗替代现有的两剂麻疹疫苗,20年后每1000例活产的发病率可降至0.0045例,风疹感染率每年降低99.9%。相比之下,单剂风疹疫苗需要更长时间才能减轻风疹和CRS的负担,并且对较低的疫苗覆盖率不太稳健。虽然本研究的结果对与东爪哇省类似的地区具有参考价值,但结论取决于疫苗覆盖率,在应用于整个印度尼西亚和亚洲其他地区之前需要考虑这一点。